(Q37831393)

24 August 2017

1 reference

title

Specific immunotherapy in asthma: efficacy and safety (English)

1 reference

24 August 2017

0 references

1 reference

1

G Passalacqua

1 reference

24 August 2017

Giorgio Walter Canonica

series ordinal

2

object named as

G W Canonica

1 reference

24 August 2017

publication date

24 January 2011

1 reference

Clinical & Experimental Allergy

24 August 2017

published in

1 reference

24 August 2017

volume

41

1 reference

24 August 2017

issue

9

1 reference

24 August 2017

page(s)

1247-1255

1 reference

Specific immunotherapy in rhinitis and asthma.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

The consideration of immunotherapy in the treatment of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Fatalities from immunotherapy (IT) and skin testing (ST)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Survey of fatalities from skin testing and immunotherapy 1985-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Evaluation of near-fatal reactions to allergen immunotherapy injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Comparison of allergen immunotherapy practice patterns in the United States and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Safety of inhalant allergen immunotherapy with mass units-standardized extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2010.03688.X

10.1111/J.1365-2222.2010.03688.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference